skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > aminopyrimidine > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > aminopyrimidine > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > aminopyrimidine > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
organic aromatic compound > aromatic amine > aminopyrimidine > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > aromatic amine > aminopyrimidine > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > aromatic amine > aminopyrimidine > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > 1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione

Preferred term

1,3'-bis(2-deoxy-beta-d-erythro-pentofuranosyl)-5-amino-5-methyl-6-/{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl/}-1,3-diazinane-2,4-dione  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • 0

formula

  • C19H27N5O9

inchi

  • InChI=1S/C19H27N5O9/c1-19(20)15(24(17(30)21-16(19)29)14-4-9(28)11(6-26)33-14)7-2-12-22(7)18(31)23(12)13-3-8(27)10(5-25)32-13/h2,7-11,13-15,25-28H,3-6,20H2,1H3,(H,21,29,30)/t7?,8-,9-,10+,11+,13+,14+,15?,19?/m0/s1

inchikey

  • XRPCSJFRSGTAEO-PBBWHBDVSA-N

mass

  • 469.447

monoisotopicmass

  • 469.18088

smiles

  • N1(C(NC(C(C1C2N3C(N(C3=C2)[C@@H]4O[C@@H]([C@H](C4)O)CO)=O)(C)N)=O)=O)[C@H]5C[C@@H]([C@H](O5)CO)O

subset

  • 3_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:132159

Download this concept: